Fundraising FoxPitango — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits.
BiotechDigital HealthHealthtechMental HealthWellness & FitnessNew York, US
Oren Fuerst, PhD(Director)Erez Raphael(Chief Executive Officer)inZvi Ben David(Chief Financial Officer, Treasurer, and Secretary)inSteven Nelson(Chief Commercial Officer)inGadi Levin(Executive Officer, Director)in
BoardAdam K. Stern(Director)
Board seatHila Karah· per SEC Form D · $17.5M raise · filed Oct 2025
Co-investorsAgate Medical Investments LPLeo Capital VenturesOrbiMed
GammaTime is a mobile streaming app offering short-form drama, romance, and true-crime series and episodes, including content partnerships branded with National Enquirer and Forensic Files.
ConsumerCreator EconomyMedia & EntertainmentSanta Monica, US
Slava M(Founder)Alex Montalvo(Founder)Bill Block(Founder)Slava Mudrykh(Founder)
Co-investorsSeven Seven Sixvgames
Localbird enables short-term rental hosts to monetize local expertise by sharing insider recommendations and experiences with guests.
Direct to ConsumerMarketplacesPropTechTravel & Hospitality
Ben Levy(CEO and Co-founder)inJoseph Levy(Co-founder)in
Co-investorsIbex InvestorsRUNI VenturesXT Venture CapitalState of Mind VenturesXT Hi-Tech
PsiQuantum builds fault-tolerant quantum computers using photonic qubits and semiconductor manufacturing processes.
Deep TechHardwareQuantum ComputingSemiconductorsMoreton Bay, AU
Prof. Terry Rudolph(Co-founder & Chief Architect)Dr. Pete Shadbolt(Co-founder & Chief Scientific Officer)inProf. Mark Thompson(Co-founder & Chief Technology Officer)Jeremy O'Brien(Co-founder & Executive Chairman)inVictor Peng(Chief Executive Officer)inMark Thompson(Founder)
Co-investorsAtomicoBlackbird VenturesC4 VenturesCold Start VenturesFOG VenturesFounders Fund+40 more
Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk.
AI & Machine LearningBiotechDeep TechBoston, US
Micha Breakstone, Ph.D.(CEO & co-founder)Allon Klein, Ph.D.(Scientific Co-founder)Olivier Pourquié, Ph.D.(Scientific Co-founder)Cliff Tabin, Ph.D.(Scientific Co-founder)Jay Shendure, M.D., Ph.D.(Scientific Co-founder)Micah Breakstone(Executive Officer, Director, Promoter)
Co-investorsFusionKhosla VenturesNext Coast VenturesSamsung NextAMD VenturesHarpoon Ventures+6 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Kneu Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.